Could your body shape predict bladder Cancer's return?

NCT ID NCT07285408

Not yet recruiting Knowledge-focused Sponsor: General Hospital Sveti Duh Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study will follow 150 adults with early-stage bladder cancer to see if factors like muscle loss, fat distribution, and nutrition affect the chance of cancer coming back or getting worse. Participants will have standard treatments and extra assessments including CT scans and questionnaires. The goal is to find better ways to predict individual risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help doctors better predict which patients are at higher risk of bladder cancer returning or worsening, leading to more personalized follow-up care.
What could go wrong: This is an observational study, not a treatment trial, so it won't directly improve outcomes. Results may show associations but not prove cause and effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER CELL TRANSITIONAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bladder transitional cell carcinoma non-invasive bladder urothelial carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CANCER CELL TRANSITIONAL

More trials for these conditions

Other studies related to the condition(s) this trial covers.